Company Overview

Development Stage

About the Company

[Summary] 创新型生物医药研发商

一家致力于发现和研发治疗肿瘤和代谢疾病生物药的创业公司。正在寻找公司各职能部门负责人和科学家,热诚欢迎有能力推进公司研发管线和培养下一代药物研发科学家的管理人员加入!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

普米斯 Financing History (5 rounds)

Manage
并购
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 8亿美元
  • Investor: BioNTech

普米斯 How Fast Is Hiring Growing? (39 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 256%
  • 2024: Up 16%
  • 2023: Down 40%
  • 2022: Flat 0%-
普米斯 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
普米斯 Campus Recruitment & Advanced Degree Talent Demand
Master's 15
Note: How fast is hiring at 百欧恩泰(珠海)医药研发有限公司 growing? 普米斯2026: 114 openings (down 46%), 2025: 210 openings (up 256%), 2024: 59 openings (up 16%), 2023: 51 openings (down 40%), 2022: 85 openings (flat), 2021: 85 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

普米斯 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 457%
  • 2024: Down 61%
  • 2023: Down 10%
  • 2022: Up 233%
普米斯 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 百欧恩泰(珠海)医药研发有限公司 growing? 普米斯Master's recruitment over the years: 2025: 39 openings (up 457%), 2024: 7 openings (down 61%), 2023: 18 openings (down 10%), 2022: 20 openings (up 233%), 2021: 6 openings.

普米斯 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 百欧恩泰(珠海)医药研发有限公司? Based on an analysis of 普米斯's job postings over the past year, "生物/制药/化工/环保类" demand: 40.9%, "其他(研发和技术类)": 17.5%, "科研类": 8.4%, "机械/仪器仪表类": 3.2%, "电气/能源/动力类": 2.6%, "计算机/网络/技术类": 1.9%. For reference only.

普米斯 — What Are the Salaries Like? (150 records)

Manage
普米斯 Salary Overview
salary range: 2K - 50K, 81.4% of roles pay ¥10-50K
Note: salary statistics are based on 150 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 百欧恩泰(珠海)医药研发有限公司?普米斯81.4% of positions earn 10-50K, Undergraduate salary: ¥。Zhuhai salary ranking top 35,工厂生产类 average salary ¥18.5K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 普米斯

(More)
Are salaries high at 百欧恩泰(珠海)医药研发有限公司? We provide: qc,分析,qa,研究员,高级经理,sa,会计,合规,理化工程师,细胞培养,仓库,ma,pe,供应链,培训,副总,运营,验证工程师,ehs,体系专员. Click to view detailed salary analysis by job.

普米斯 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

普米斯 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 工厂生产类
    43.5% of total 43.5%
  • 生物/制药/化工/环保类
    40.9% of total 40.9%
  • 质量管理类
    27.9% of total 27.9%
  • 经营管理类
    20.1% of total 20.1%

Education

  • 本科
    75.3% of total 75.3%
  • 硕士
    15.6% of total 15.6%
  • 大专
    8.4% of total 8.4%
  • 不限
    0.6% of total 0.6%

Experience

  • 不限
    47.4% of total 47.4%
  • 5-10年
    37.7% of total 37.7%
  • 3-5年
    10.4% of total 10.4%
  • 1-3年
    4.5% of total 4.5%
View Detailed Analysis

What does 百欧恩泰(珠海)医药研发有限公司 require? Who is 普米斯 hiring? 普米斯 recruitment: 工厂生产类占比最多占43.5%,其次是生物/制药/化工/环保类占40.9%. What education can get in at 普米斯? 本科占比最多占75.3%,其次是硕士占15.6%. High education required at 普米斯? 硕士占15.6%. Work experience required at 普米斯? 不限占比最多占47.4%,其次是5-10年占37.7%. Where are the job locations at 普米斯? 南通占比最多占70.1%,其次是珠海占26.6%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 26,795.4321万(美元)
Legal Representative: LIU XIAOLIN
Date Established:
Credit Code: 91440400MA51YKAW2M
Registered Address: 珠海市香洲区唐家湾镇科技七路1号4栋10-B单元

Partners & Suppliers

上海复星医药产业发展有限公司获得百欧恩泰母公司BioNTech SE的mRNA新冠疫苗在中国大陆及港澳台地区的独家开发、商业化许可,并向BioNTech支付许可费及销售分成。 Source
合作客户 医疗

People who follow 普米斯 also follow

普米斯 Competitors (Similar Companies)

医药 制药/药业 医药工业 创新药
制药/药业 医药 生物制药 神经系统疾病药物
制药/药业 医药 生产 医药分析
生物制药 脑科学 神经系统疾病药物 神经科学
医药 创新药 药物研发 产业园区开发
“专注于核酸诊断试剂核心原料领域”
公务机 制造 固定翼 低空经济
义齿 义齿加工 齿科 健康体检
“To develop high-quality biologics that are accessible and affordable f”
“A well-known multinational company in the global ophthalmic optics and”
“is a modern, international, Sino-foreign joint venture pharmaceutical ”
“We focus on scientific innovation, exploring, developing, and providin”
“Making Life Healthier”
“Pioneer and leader in China's third-party testing and certification se”
“Continuously innovating to bring patients medicines that significantly”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates